Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion type Assertion NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_head.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion evidence source_evidence_literature NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion SIO_000772 16239914 NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion wasDerivedFrom befree-20140225 NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion wasGeneratedBy ECO_0000203 NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.